Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of human oesophageal adenocarcinoma OE19 cell line following PPARGC1A knock-down and 24 hour lapatinib treatment


ABSTRACT: To determine genes regulated by the transcriptional co-activator PPARGC1A in OAC cells and whether PPARGC1A activity is altered by lapatinib we performed RNA-seq on OE19 cells treated with non-targeting siRNA or siRNA targeting PPARGC1A. 24 hours post-transfection, cells were also treated with either DMSO or 500 nM lapatinib for 24 hours.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER: Andrew Sharrocks 

PROVIDER: E-MTAB-10317 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition.

Ogden Samuel S   Carys Kashmala K   Ahmed Ibrahim I   Bruce Jason J   Sharrocks Andrew D AD  

Oncogene 20220924 43


Oesophageal adenocarcinoma (OAC) patients show poor survival rates and there are few targeted molecular therapies available. However, components of the receptor tyrosine kinase (RTK) driven pathways are commonly mutated in OAC, typified by high frequency amplifications of the RTK ERBB2. ERBB2 can be therapeutically targeted, but this has limited clinical benefit due to the acquisition of drug resistance. Here we examined how OAC cells adapt to ERBB2 inhibition as they transition to a drug resist  ...[more]

Similar Datasets

2022-09-26 | E-MTAB-11300 | biostudies-arrayexpress
2022-09-26 | E-MTAB-10304 | biostudies-arrayexpress
2022-09-26 | E-MTAB-10314 | biostudies-arrayexpress
2022-09-26 | E-MTAB-10319 | biostudies-arrayexpress
2022-09-26 | E-MTAB-10302 | biostudies-arrayexpress
2024-09-25 | E-MTAB-14095 | biostudies-arrayexpress
| PRJEB49950 | ENA
2016-06-15 | E-GEOD-81546 | biostudies-arrayexpress
2016-07-28 | E-GEOD-84896 | biostudies-arrayexpress
2023-02-24 | E-MTAB-11357 | biostudies-arrayexpress